Real-world effectiveness of early revascularization in stable coronary artery disease with moderate or severe ischemia.

ABSTRACT:

Background

Comparative effectiveness studies may provide insights into generalizability of the ISCHEMIA trial to real-world patients. We evaluated the long-term effectiveness of revascularization within 90 days after detecting moderate or severe ischemia on myocardial perfusion imaging (MPI) in stable coronary artery disease.

Methods

All consecutive patients with moderate or severe ischemia (summed difference score ≥7) on single photon emission computed tomography MPI at a tertiary academic medical center were included (January 2003 to March 2020). Early revascularization (defined as percutaneous coronary intervention or coronary artery bypass grafting within 90 days) after MPI, was compared to those patients treated without early revascularization, excluding those with left

SUBMITTER: Gerodias FJ 

PROVIDER: S-EPMC12424251 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature